FDA Approves CAPECITABINE — Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited received FDA approval for its generic capecitabine, an oral chemotherapy agent, strengthening its position in the U.S. oncology market and expanding its revenue-generating portfolio.